cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors - KitMel Project
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
c-Kit exons 11, 13, 17 and 18 will be sequenced (direct sequencing and pyrosequencing when possible)
c-Kit exons 11, 13, 17 and 18 will be sequenced (direct sequencing and pyrosequencing when possible)
Day 1
No
Marie-Dominique Galibert, PU-PH
Principal Investigator
Rennes University Hospital
France: The Commission nationale de l’informatique et des libertés
LOC/10-16 - KitMel
NCT01543113
January 2011
January 2015
Name | Location |
---|